PFSA - Rasio utang marang kapitalisasi buku Profusa Inc.

Profusa Inc business development is based on the implementation of subcutaneous oxygen sensors in clinics. The implantable sensor technology does not yet generate regular revenue, and the production cycle relies on in-house laboratories and external assemblers. This chart of the debt-to-equity ratio demonstrates the dynamics of the debt load, where 0.00 shows the current value of the metric.

Profusa Inc - Utang-utang marang kapitalisasi buku PFSA (periode 15.07.2025 - 27.10.2026)

For Profusa Inc (PFSA), the ratio of total debt to the book value of assets determines the stability of the capital structure during the implementation phase of biosensor technologies. This metric measures the share of borrowed funds in total capitalization, reflecting the degree of financial leverage. By analyzing the trend of debt obligations relative to capitalization, an investor assesses the risk of default in the absence of stable revenue. A reduction in this coefficient minimizes dependence on external borrowing, which is critically important for a company whose income depends on the integration of devices into medicine.

Pesaing Profusa Inc

DXCM: Utang-utang marang kapitalisasi buku|penumbrainc.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Novanta (NOVT)|HAE - Rasio utang marang aset resik|INSP: Utang-utang marang kapitalisasi buku|PRCT (Procept) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation CNMD|Rasio utang-utang marang kapitalisasi buku pulsebiosciences.com|InMode - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Picard Medical Corp PMI|Utang marang nilai buku SRDX (Surmodics Corp)|SENS - Utang-utang marang kapitalisasi buku|Utang marang nilai buku NeuroPace, Inc. NPCE|TCMD - Utang marang modal buku|SANUWAVE - Utang-utang marang kapitalisasi buku|Outset Medical Inc (OM) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku ELMD|Utang marang nilai buku LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Utang marang nilai buku|Rasio utang marang aset resik PROF (profoundmedical.com)|Baird Medical - Rasio utang marang kapitalisasi buku|Utang marang nilai buku EDAP TMS SA EDAP|APYX (Bovie Medical) - Utang-utang marang kapitalisasi buku|ICCM - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku pulmonx.com|TELA Bio (TELA) - Rasio utang marang nilai buku|CTSO: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Sensus Healthcare Inc|Utang-utang marang kapitalisasi buku ZYXI (Zynex Inc)|Utang marang nilai buku electrocore.com (ECOR)|Utang-utang marang kapitalisasi buku RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Utang-utang marang kapitalisasi buku|ICU - Rasio utang marang kapitalisasi buku|IRIDEX Corporation (IRIX) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku ibs.inc INBS|Beyond Air (XAIR) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku SSKN (STRATA Skin Sciences Inc.)|Utang-utang marang nilai buku GCTK|NAOV: Rasio utang marang kapitalisasi buku|Utang marang aset resik Venus Concept Inc VERO|Utang marang nilai buku NUWE (CHF Solutions)|Utang-utang marang kapitalisasi buku Aethlon Medical Corp AEMD|Utang-utang marang kapitalisasi buku ASXC (TransEnterix)|AVGR: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku KNW|Utang marang nilai buku Inari Medical Corp|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku